Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. MOORE'S PHARMACY INC
WARNING LETTER
•MOORE'S PHARMACY INC•September 1, 2016

MOORE'S PHARMACY INC – FDA Warning Letter, Sep 1, 2016

Record Details

On September 1, 2016, the FDA issued a Form FDA 483 to Moore's Pharmacy, Inc. following an inspection from August 25 to September 1, 2016. The inspection revealed that drug products produced by Moore's Pharmacy, Inc. failed to meet the conditions of section 503A of the Federal Food, Drug, and Cosmetic Act (FDCA), specifically regarding the requirement for valid prescriptions for individually-identified patients. This failure means the compounded drug products are not exempt from FDA approval, adequate labeling, and current good manufacturing practices (CGMP).

The FDA investigator observed insanitary conditions, including a dead cockroach in the drug production room, a hole in the ceiling exposing insulation, and gaps under doors leading to an uncontrolled warehouse. These conditions render the drug products adulterated under section 501(a)(2)(A) of the FDCA. Additionally, significant CGMP violations were noted, including failure to maintain clean and sanitary buildings free of vermin (21 CFR 211.56(a)), failure to investigate discrepancies (21 CFR 211.192), and failure to ensure expiration dates were supported by stability testing (21 CFR 211.137(a)). The ineligible drug products are also considered misbranded under section 502(f)(1) of the FDCA due to inadequate directions for use

Company
MOORE'S PHARMACY INC
Inspection date
September 1, 2016
Product type
Drugs
Office
Dallas District Office
People
  • Gay Dodson
  • Karen Tannert
  • Amanda Lawrence
  • Monica R. Maxwell (Program Division Director)
View Company Profile

ID · c935605f-8985-478f-8313-79385eccf44a

Violation Codes10
21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 351(a)(2)(A)21 CFR 21021 CFR 21121 CFR 211.56(a)21 CFR 211.19221 CFR 211.137(a)21 CFR 200.10(b)

Full citation text and observation details available on the Dashboard.

Other documents for MOORE'S PHARMACY INC
  • 483 - 2016-09-01September 1, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MOORE'S PHARMACY INC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.